Nanobret ™ -Based Assay for Internalization of cxcr4
CRISPR/Cas9 genome-edited cells express nanoBRET-donor that monitors protein interaction and trafficking more
Nanobret ™ -Based Assay for Internalization of cxcr4
Read how GPCRs are studied at endogenous expression levels by employing CRISPR/Cas9.
Andrea KrummGPCRs are important drug targets requiring receptor-protein interaction and trafficking studies to reveal how they function. Bioluminescence resonance energy transfer (BRET) is a versatile tool to study such interactions and trafficking. Hitherto, it is limited by the ectopic expression of labelled interaction partners. CRISPR/Cas9 genome editing overcomes the limitation by enabling endogenous expression of luciferase-labelled proteins. CRISPR/Cas9-edited cells endogenously expressing a CXCR4/NanoLuciferase fusion protein were used in conjunction with β-Arrestin/Venus to monitor receptor activation. Employing two fluorophores fused to a membrane and endosome standing CXCR4-interacting protein, respectively, allowed for monitoring of receptor trafficking. The novel CRISPR/Cas9 technique successfully fused the Nluc BRET donor to endogenously-expressed CXCR4. The resulting protein levels were sufficient to monitor receptor interactions as well as internalization. The internalization assay depends on two acceptor fluorophores whose selective detection was rendered possible by the CLARIOstar’s monochromator.
Facts, background information, dossiers
- luciferase
- genome editing
- CRISPR/Cas9
- G protein-coupled receptors
- fusion proteins
- BRET assays
- receptor-protein in…
- genomes
- fluorophores
More about BMG Labtech
-
White papers
Homogeneous IgG AlphaLISA® assay performed on BMG LABTECH's PHERAstar Plus
Immunoglobulins or antibodies are proteins that are involved in the immune response. That makes them interesting drug targets. This application note shows the detection of the immunoglobulin IgG using an AlphaLISA® assay performed on BMG LABTECH's PH more
-
News
BMG LABTECH invests 4.5 million Euro in headquarters site expansion
BMG LABTECH has recorded a rapid increase in revenue over the past years. A new company building provides the additional capacity required for the company's anticipated business growth over the longer term. The expansion is a necessary response to the global demand for BMG LABTECH products ... more
2012 Nobel Prize in Chemistry Uses Research Equipment Engineered Locally from BMG LABTECH
Robert J. Lefkowitz from Duke University, along with Brian Kobilka from Stanford University, were just awarded the 2012 Nobel Prize in Chemistry for their research and discovery of the receptor protein that binds to adrenaline, that is the beta-adrenergic receptor. A receptor protein crosse ... more
BMG LABTECH’s First Winner of a SPECTROstar Nano Could Change the Way We Look at Beer
One of the first uses of the microscope by Louis Pasteur was to determine why beer and wine soured; he later hypothesized the Germ Theory of Disease. It’s in that same spirit that BMG LABTECH congratulates Dr. Gary Spedding for his proposal to use the new SPECTROstar Nano to modernize beer ... more
Most read white papers
- 1Microwave freeze drying of fruits & vegetables
- 2Asymmetric Flow Field Flow Fractionation (AF4) - A Powerful Method for Polymer Characterization
- 3Comparing ICP-OES Analyzers' Plasma Views: Axial, Radial, Dual, MultiView, and New Dual Side-On Interface
- 4Automated Dynamic Light Scattering
- 5Risks and Hazards Caused by ELECTROSTATICS in the LAB?!
- 6Field-Flow Fractionation - The Universal Separation Principle for Particle and Macromolecule Characterization
- 7Why ICP-OES User Are Moving up to the Latest Technology
- 8Benefits of Deep Learning and AI in Microscopy: Label-Free Nucleus Detection in Micro Well Plates
- 9ETC Powder Dispensing Study
- 10Polyether-Modified Silicones for Cosmetic Applications
